Phase I trial of TC 5619 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 May 2008
At a glance
- Drugs Bradanicline (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 08 May 2008 Status changed to completed by May 2008, according to a Targacept media release.
- 08 Aug 2007 New trial record.